معرفی
Juris Jansons is an active researcher at Riga Stradins University's Faculty of Pharmacy, serving as Leading Expert and Project Leader in multiple national and international research initiatives funded by the Latvian Council of Science and Polish National Agency for Academic Exchange. His work spans virology, cancer research, and vaccine development with significant contributions to HPV and HIV studies.
His research focuses on DNA immunization techniques, viral pathogenesis, and cancer biomarker discovery. Key areas include HPV vaccine development using mouse models, prostate cancer liquid biopsies, and innovative approaches to combat HIV drug resistance. His fingerprint reveals strong expertise in Reverse Transcriptase, HIV-1, Prostate Cancer, and DNA Vaccination with 75-100% relevance across publications.
Recent publications demonstrate cutting-edge work in HPV therapeutic models (2025), prostate cancer RNA biomarkers (2023), and fluorescent imaging probes (2023). His research consistently addresses UN Sustainable Development Goals in biological sciences, particularly advancing medical diagnostics and vaccine technologies.
Jansons actively mentors doctoral students including Dudorova A. and collaborates extensively through projects like EUROPARTNER with University of Lodz. He organizes international conferences including 'Vaccines and Vaccination During and Post Covid Pandemics' (2022) and presents regularly at major scientific forums.
Current projects include:
- Human papillomavirus genome correlates in cervical cancer (2022-2024)
- Hepatitis C virus pathogenicity research (2020-2021)
- EUROPARTNER international research collaboration (2018-2022)
